Evaluation of Plasmodium falciparum gametocyte detection in different patient material by unknown
Kast et al. Malaria Journal 2013, 12:438
http://www.malariajournal.com/content/12/1/438METHODOLOGY Open AccessEvaluation of Plasmodium falciparum gametocyte
detection in different patient material
Katharina Kast1†, Nicole Berens-Riha1,2*†, Ahmed Zeynudin4, Nuredin Abduselam4, Teferi Eshetu4,
Thomas Löscher1,2, Andreas Wieser2,3, Jonathan Shock5 and Michael Pritsch1,2Abstract
Background: For future eradication strategies of malaria it is important to control the transmission of gametocytes
from humans to the anopheline vector which causes the spread of the disease. Sensitive, non-invasive methods to
detect gametocytes under field conditions can play a role in monitoring transmission potential.
Methods: Microscopically Plasmodium falciparum-positive patients from Jimma, Ethiopia donated finger-prick blood,
venous blood, saliva, oral mucosa and urine samples that were spotted on filter paper or swabs. All samples were
taken and stored under equal, standardized conditions. RNA was extracted from the filter paper and detected by
real-time QT-NASBA. Pfs16-mRNA and Pfs25-mRNA were measured with a time to positivity to detect gametocyte
specific mRNA in different gametocyte stages. They were compared to 18S-rRNA, which is expressed in all parasite
stages. Results were quantified via a known dilution series of artificial RNA copies.
Results: Ninety-six samples of 16 uncomplicated malaria patients were investigated. 10 (66.7%) of the slides
showed gametocyte densities between 0.3-2.9 gametocytes/μl. For all RNA-targets, molecular detection in blood
samples was most sensitive; finger-prick sampling required significantly smaller amounts of blood than venous
blood collection. Detection of asexual 18S-rRNA in saliva and urine showed sensitivities of 80 and 67%, respectively.
Non-invasive methods to count gametocytes proved insensitive. Pfs16-mRNA was detectable in 20% of urine
samples, sensitivities for other materials were lower. Pfs25-mRNA was not detectable in any sample.
Conclusions: The sensitivity of non-invasively collected material such as urine, saliva or mucosa seems unsuitable
for the detection of gametocyte-specific mRNA. Sensitivity in asymptomatic carriers might be generally even lower.
Finger-prick testing revealed the highest absolute count of RNA copies per μL, especially for Pfs25-mRNA copies.
The method proved to be the most effective and should preferably be applied in future transmission control and
eradication plans. A rapid test for gametocyte targets would simplify efforts.Background
The presence of mature Plasmodium falciparum sexually
committed parasites, so-called stage V gametocytes, is
necessary for transmission from humans to anopheline
vectors, while the asexual stages are responsible for the
clinical symptoms of the disease.
Malaria remains one of the world’s leading health
problems. In 2010, about 216 million cases of malaria and
an estimated 665,000 deaths occurred. Approximately half* Correspondence: berens@lrz.uni-muenchen.de
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reproduction in any medium, provided the orof the world’s population is at risk of malaria [1]. Studies
investigating the infectious reservoir were for a long time
neglected, but recognition of their relevance has increased
in the recent years as eradication of malaria is on the
agenda of many countries [2].
It was previously shown that gametocyte densities below
the detection limit of microscopy can still lead to mosquito
infection [3-6]. To bridge this gap and to quantify the
infectious reservoir, modern molecular techniques were
introduced [7,8]. In this study, quantitative nucleic acid
sequence based amplification (QT-NASBA) was used,
which offers a limit of detection (LOD) down to 0.02
gametocytes per μL [9].
An obstacle for large-scale epidemiological investigations
in the context of malaria elimination and eradication is the. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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healthy individuals by finger prick or venepuncture. Apart
from ethical difficulties concerning invasive methods in po-
tentially healthy carriers, risks of infection for the examiners
via blood contact as well as cultural taboos impede such
studies. Repeated blood sampling is especially problematic
in the population groups that are affected frequently:
infants, young children and pregnant women.
It was shown in previous studies that the DNA of
asexual parasites of P. falciparum can be detected by
PCR from urine and saliva samples. Results from saliva
and urine had a significant or at least positive correlation
with microscopy counts [10,11]. To differentiate between
sexual and asexual forms in malaria, RNA amplification is
necessary. RNA detection in tissue and saliva is becoming
established i.e. for mycobacterioses to evaluate therapy
success [12-14].
In this small pilot study, the detection of gametocyte
specific mRNA from microscopically P. falciparum-positive
patients was investigated in urine and saliva samples as
well as mucosa swabs. Results were compared with the
detection of 18S-rRNA, which is expressed in all parasite
stages. Furthermore, the quantity of gametocyte specific
mRNA from finger-prick samples was compared with
venepuncture samples.
Methods
Study area and patients
The study was conducted in the Jimma Zone in Oromiya
regional state, around its capital in the hilly area at around
1650 m above sea level. The city of Jimma is located
255 km southwest of the Ethiopian capital, Addis Ababa.
The area is malaria endemic with a low to moderate
transmission. The predominant species in most areas
is P. falciparum, followed by Plasmodium vivax. Most
cases occur from September to December after the
main rainy season from June to August. Recruitment
of study patients took place in September 2012. The
study site was K'Och'e Health Centre, 30 km northwest
of Jimma town. The study was implemented during the
routine diagnostic practices of the health centre. Blood
slides were collected from all patients with fever. Only
P. falciparum mono-infection was considered for the study.
After microscopic confirmation, patients were informed
about the study and included if consent was given.
Inclusion criteria were age above 14 years, uncomplicated
mono-infection with P. falciparum malaria, parasite
densities up to 100,000/μL and informed consent by
the patient or the legal representative when appropri-
ate. Exclusion criteria were any anti-malarial treatment
within the previous three weeks (anti-malarials such
as chloroquine, artemether-lumefantrine, quinine and
others as well as antibiotics with anti-malarial effects
such as doxycycline, clindamycine), mixed plasmodialinfection, danger signs (inability to drink, repeated vomiting,
recent history of convulsions, lethargy or unconsciousness)
and signs of severe malaria as defined by the WHO [15] as
well as pregnancy or lactation.
Ethical considerations
Each patient (or parent/guardian) received oral and written
information about the study and signed an informed con-
sent form. Ethical approval was obtained from the Ethical
Committee of the Faculty of Medicine of the Ludwig-
Maximilian-University (LMU) in Germany and from the
Ethical Board of Jimma University, the Ethiopian Federal
Ministry of Science and Technology, in Ethiopia.
Sample collection and handling
Blood slides were prepared at the initial presentation for
all patients with fever or history of fever within 24 hours,
during routine examination at the study centre. Sampling
and preparation of thin and thick smears were performed by
physicians or laboratory technicians who had been trained
and instructed by the investigators at the beginning of the
study. For determination of parasitaemia and gametocy-
taemia, thick blood smears of 10 μL blood were prepared
according to standard procedures. Slides were stained with
10% Giemsa for 20 min and independently read by two ex-
perienced microscopists. Asexual parasites were counted
on thick blood films against 200 white blood cells (WBCs).
The parasite density was calculated assuming an average
WBC count of 8,000/μL. Slides were declared negative if no
parasites were seen in 200 fields of the thick film.
After recruitment, different samples were taken before
treatment was initialized. Venous blood was drawn from
the left bend of the elbow if right handed, and otherwise
vice versa. A finger-prick examination was then performed.
The patients were asked to donate urine and saliva samples.
Furthermore, two independent mucosal swabs were taken.
One swab was dried and frozen directly. The other was
spread on filter paper (Standard-Whatman Cellulose
Chromatography paper 3MM, GE Healthcare, Fairfield,
CT, USA) immediately after taking the sample. Three lots
of 100 μL of saliva, urine and venous blood, respectively,
as well as 25 μL blood from finger prick were spotted
on filter papers. Those were dried for three hours at
room temperature. After drying, all samples were indi-
vidually sealed in labelled plastic bags and stored in a
freezer at -30°C. Samples were transported to Germany
on dry ice and processed consecutively. All samples
were analysed within one month. During this process,
filter papers were stored at -20°C to avoid decay.
RNA extraction
For analysis, the samples containing 100 μL of venous
blood, 100 μL of urine, 100 μL of saliva, 25 μL of finger-
prick blood and the mucosal swab spread on filter paper
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maintaining a distance of approximately 3 mm to the
border of the sample. The spots and the head of the sec-
ond mucosal swab smear were subsequently soaked in
2 ml NucliSens easyMAG (bio Merieux, Lyon, France)
lysis buffer containing guanidiumisothiocyanate (GuSCN)
and rocked at 150 rpm for 30 min at room temperature.
The solution was then centrifuged at 1,500 g for 5 min.
Afterwards the filter paper and the head of the smear were
removed and 50 μL of silica particle solution (bio Merieux,
Lyon, France) was added to each tube. Thereafter, the
RNA extraction method originally described by Boom
et al. was performed and then the nucleic acids were
eluted from the silica with 30 μL elution buffer provided
by the manufacturer [16].
For each extraction, a negative control of 100 μL of
Plasmodium-negative full blood spotted on filter paper
and a positive control of 100 μL of Plasmodium-spiked
(NF54 strain) full blood spotted on filter paper was used.
After extraction the samples were either stored at -80°C
for a maximum of 24 hours or immediately amplified using
NABSA method.
Real-time quantitative nucleic acid sequence-based
amplification (QT-NASBA)
The primer and probes for Pfs16-mRNA, Pfs25-mRNA
and 18S-rRNA were chosen as described earlier and were
used at a final concentration of 290 nM for the primers
and 145 nM for the probes [17,18]. All oligonucleotides
used in this study are summarized in Table 1.
QT-NASBA was performed using the NucliSens Basic
Kit for amplification according to the manufacturer’s manualTable 1 Oligonucleotides used for NASBA, hybridization and
Oligonucleotides Sequence
Pfs16.F WT 5‘-AGT TCT
Pfs16.R WT 5’-T7-AGC
Pfs16.F Q 5’-CAA CA
Pfs16.R Q 5’-AGA AT
Pfs16 probe 5’-6-FAM-C
Pfs25.F WT 5‘-GAC TG
Pfs25.R WT 5‘-T7-CAT
Pfs25.F Q 5’-GAA TTC
Pfs25.R Q 5’-AAG CTT
Pfs25 probe 5‘-Texas Re
18S.F WT 5’-GTC ATC
18S.R WT 5’-AAC TTT
18S probe 5’-6-FAM-C
M13.F 5'-GTA AA
M13.R 5'-CAG GAat a final volume of 20 μL. Pfs16-mRNA, Pfs25-mRNA and
18S-rRNA were chosen as target sequences of 111 base
pairs, 156 bp and 100 bp, respectively. Pfs16-mRNA is the
earliest marker available to detect gametocytogenesis and
is expressed in all sexual parasite stages. Pfs25-mRNA is
expressed only in the female stage V gametocytes, which
allows separate quantification of mature gametocytes
[19,20]. 18S-rRNA is expressed in all sexual stages as well
as asexual stages.
Amplification was performed using NucliSENS EasyQ®
Basic Kit (bio Merieux, Lyon, France) according to the
manufacturer’s manual and as described recently [9].
Positivity was measured with the time to positivity (TTP)
according to the time at which the readings passed a given
threshold.
Artificial RNA of Pfs16 and Pfs25
The primers Pfs16.F Q and Pfs16.R Q were used to amplify
a 481 bp region of encoding a domain located to the para-
sitophorous vacuole membrane as described by Schneider
et al. [20]. The amplified DNA from the K1 culture
was cloned into TOPO plasmid and transformed into
TOP10 cells.
DNA was extracted from overnight cultures and served
as the PCR template with M13 Primers. Subsequently,
the required band was amplified and Gel purified with
the QIAgen Gel Extraction Kit (Qiagen N V, Venlo, the
Netherlands) and used for in vitro transcription with T7
RNA polymerase (AmpliScribe™ T7-Flash™ Transcription
Kit by Epicentre® Biotechnologies, Madison, WI, USA).
To ensure the purity for large quantities of RNA, a
DNA digestion and RNA purification (RNAeasyin vitro RNA
5´ to 3´
TCA GGT GCC TCT CTT CA-3‘
TAG CTG AGT TTC TAA AGG GCA-3’
T GAA TAT TCG AAA GTT CAT ACC-3’
C ATC TCC TTC GTC TTC TTC-3’
GATCG-GCT GTT GGA CCT AAT CTA ATC TAG GTG GA-CGATCG-Dabsyl-3‘
T AAA TAA ACC ATG TGG AGA-3‘
TTA CCG TTA CCA CAA GTT A-3‘
GAC TGT AAA TAA ACC ATG TGG AGA-3’
CAT TTA CCG TTA CCA CAA GTT A-3’
d-CGATCG-CCC GTT TCA TAC GCT TGT AA-CGATCG –Dabsyl-3’
TTT CGA GGT GAC TT-3’
CTC GCT TGC GCG AA-3’
GATCG-GAG AAA TCA AAG TCT TTG GG-CGATCG-Dabsyl-3’
A CGA CGG CCA GT-3'
A ACA GCT ATG AC-3'
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Netherlands) was performed. In vitro RNA was quantified
by measuring the exact RNA amount and purity by Bio
Analyzer (Agilent RNA 6000 Nano Kit, by Agilent
Technologies, Santa Clara, CA, USA). A ten-fold dilu-
tion series from 1.28 * 105 to 1.28 *1010 per μL was used
in each NASBA run as a standard normalization.
The primers Pfs25.F Q and Pfs25.R Q were used to amplify
a 156 bp region of Pfs25 located in the osmiophilic bod-
ies [20]. The in vitro RNA was obtained as described for
Pfs16. A ten-fold dilution series from 9.06 * 105 to 9.06 *
1010 per μL was used in each NASBA run as standard.
Lengths of RNA fragments after in vitro transcription
were 623 bp and 298 bp for Pfs16 and Pfs25, respect-
ively. The results of the Bio Analyzer run are presented
in Additional file 1: Figure S1.Parasite culture
To gain RNA templates for artificial RNA and positive
controls for the NASBA, parasites were obtained from
a continuous in vitro parasite culture of P. falciparum
(strain NF 54 and K1). The culture was grown in sterile
filtered medium (RPMI 1640 supplemented with 25 mM
HEPES, 25 mM sodium bicarbonate, 25 mg/l gentamicin
sulphate, 2% D-glucose, and 10% human type AB serum,
pH 7.4) with additional erythrocytes to uphold a haemato-
crit of 5%. New medium to feed the culture was added
twice daily. The cultures were kept under a gas phase
of 3% O2, 5% CO2 and 92% N2 [21,22]. For gametocyte
culture, medium without antibiotic was used. To gain
gametocytes enriched cultures for positive controls, the cul-
tures were treated with N-Acetyl-Glucosamine 5% from
day 4 to day 9. Mature gametocytes were harvested at day
14 as described before [9].Sample size
A recent DNA-based malaria study showed a sensitivity
of 73% and 32% for saliva and urine samples, respectively,
compared to microscopy of blood [11], similar sensitivities
were assumed for 18S-rRNA detection. The same applied
for gametocyte-specific diagnostic although lower preva-
lences and sensitivities were assumed. Based on experi-
ence and literature [17,18], microscopic gametocytaemia
in blood in 20% of the samples by reading 200 fields and
in 40-60% by reading the whole slide were expected.
Pfs16-mRNA and Pfs25-mRNA detection by QT-NASBA
was assumed in 100% and in 70-90%, respectively. Choos-
ing a confidence interval normal distribution value of 90%
(z = 1.65), an accuracy of 0.1 and a prevalence of 90%,
a sample size of at least 15 patients was calculated.
Intended sensitivity was set 95%. Used formulae were:
TPþ FN ¼ z2  SN 1‐SNð Þð Þ
W2
and N sNð Þ ¼ TPþFNP [23].Data analysis
Data were analysed with Microsoft Excel and Mathematica
9.0 (Wolfram Research, Champaign, IL, USA). The data
from the NASBA runs, originally in Microsoft Excel for-
mat, were imported into the Mathematica programming
environment. For Pfs16, for each of the six NASBA runs
there was an RNA dilution series, which was used as a
benchmark to calculate the RNA copy numbers for the
patient samples. For each sample in each run, a time to
positivity (TTP) was calculated by finding at what point
the measurement went above a cut-off. In the case of
Pfs16 this cut-off was 1.234306 fluorescence signal. The
final results were not sensitive to the exact value of this
cut-off because the normalization was made using the
known RNA dilution series. Once the TTP for the RNA di-
lution samples had been calculated, a relationship between
TTP and RNA copy numbers was calculated. This relation-
ship was unique to each run due to the slight variations in
experimental conditions, but the normalization of RNA
copy numbers allows for this variation. After the relation-
ship between TTP and RNA copy numbers had been
calculated (a logarithmic relationship between 1/TTP
and log_10 RNA copy number), the RNA quantities for
the patient samples could be calculated.
Because there was a large variation in absolute RNA
quantities between the patients, the absolute value of
the RNA count was not a good comparison to make
across the different quantification methods (venous
blood, finger-prick blood, mucosa, etc), so instead the
ratio between the venous blood measurements and the
other measurements was calculated for each patient.
The average for the ratios for each method was then
calculated and the standard deviation in the ratios
given. Thus, the final quantification for a given sample
type was the average of the ratios of the RNA count
between that method and the RNA count of venous
blood. For example: where # patients = total number
of patients.
A second measure was given for the power of a meas-
urement technique. This was the total number of sam-
ples which came out as positive.
For Pfs25, the same procedure was used, but the cut-off
for the TTP was calculated from the fluorescence mean of
a set of negative controls (their value at 90 min) plus 20
standard deviations of these measurements. This ensured
that no negative results would show up as false positives.
In this case, the three negative NASBA measurements at
90 min were 1.00533, 1.00199 and 0.99369, giving a cut-
off of 1.06196 mean fluorescence signal. Again, the final
results were not sensitive to this value as the RNA dilu-
tion series normalization took into account the variation
in cut-off to define the TTP.
For 18S the same procedure as the previous two was
used, but there was no RNA quantification. Only the
Table 2 Qualitative QT-NASBA results for Pfs16, Pfs25
and 18S in different patient material
Pfs16 Pfs25 18S
m/N (%) m/N (%) m/N (%)
Venous blood 100 μL 15/15 (100.0) 11/15 (73.3) 14/15 (93.3)
Finger prick 25 μL 15/15 (100.0) 10/15 (66.7) 15/15 (100.0)
Urine 100 μL 3/15 (20.0) 0 10/15 (66.7)
Saliva 100 μL 2/15 (13.3) 0 12/15 (80.0)
Mucosa swab 1/15 (6.7) 0 2/15 (13.3)
Mucosa filter paper 2/15 (13.3) 0 8/15 (53.3)
(m = positive samples, N = all samples).
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ferent measurement techniques was quantified.




RNA of finger prick blood for patient i
RNA of venous blood for patient i
To calculate the RNA copy numbers, the molecular
weight (MW) of the artificial RNA of Pfs16 and Pfs25
was calculated using the formula for single stranded
RNA: MW= (An x 329.2) + (Un x 306.2) + (Cn x 305.2) +
(Gn x 345.2) + 159. This resulted for Pfs16 in a MW of
200576.6 Dalton [Da] (MW= (211 x 329.2) + (174 x 306.2) +
(112 x 305.2) + (126 x 345.2) + 159) and for Pfs25 in
96043.6 Da (MW = (90 x329.2) + (95 x 306.2) + (46 x
305.2) + (67 x 345.2) + 159). RNA/μL was given in ng/μL by
the Bio Analyzer. The amount of RNA/μL of the measured
peaks which represented either Pfs16 or Pfs25 was divided
by their MW to gain the copy number/μL: Pfs16 =
2.5600867417625E + 15 [Da/μL]/ 200576.6 Da = 12 763
636 146/μL and Pfs25 = 8.7042949219927E + 15 Dalton
[Da/μL]/ 96043.6 Da = 90 628 578 291/μL).
Results
Baseline data
The study centre is situated in the hilly area near Jimma
at around 1,650 m above sea level. The study was imple-
mented during the routine diagnostic practices of the clinic.
Sixteen patients with microscopically uncomplicated
P. falciparum malaria were enrolled. Ninety-six samples
from 16 patients were extracted and subsequently analysed
by QT-NASBA. One patient was negative for all targets,
species PCR revealed infection with Plasmodium malariae;
the patient was therefore excluded from the study.
The median age of the 15 remaining patients was 18 years
(range 14-70 years); 33% were female and 40% had fever
at admission. The median temperature at admission
was 37.0°C (range 36.4-40.0°C). The geometric mean of
the parasitaemia was calculated to be 9,320/μL (95% CI
7,298-11,701/μL). No gametocytes could be detected
during initial microscopy of 200 fields at recruitment.
Repeated microscopic examination of the whole blood
slide revealed a median gametocyte density of 7 stage V
gametocytes per 10 μL (range 3-29) in the slides of 10
patients. In five patients, none were detectable in 10 μL.
Qualitative RNA detection in patient material
Table 2 shows qualitative data for RNA detection of all
three targets. The marker for asexual and sexual parasites,
18S-rRNA, was detectable in all finger-prick samples
(Figure 1). Venous blood samples from one patient remained
repeatedly negative although geometric mean parasitaemia
showed an average density level when compared with theother patients. Mutations at the primer binding site or in-
hibition were unlikely as finger-prick blood was positive.
18S-rRNA detection in saliva was sensitive (80%) but the
target could only be amplified in two-thirds and in one-half
of the urine and mucosa samples, respectively. Interestingly,
the mucosa on filter paper performed four times better
than the mucosa swab preparation.
RNA amplification with Pfs16 primers showed 100%
sensitivity in blood samples. Detection of Pfs16-mRNA
in saliva, urine and mucosa was low (Figure 1). Urine
performed best of these with a detection rate of 20%.
RNA from mature gametocytes was detectable in venous
blood samples from 11 patients and in finger-prick samples
from ten patients. The blood slide from the discordant pair
showed no gametocytes in the microscopic investigation.
The non-invasive material was completely negative for ma-
ture gametocytes by QT-NASBA (Figure 1).
Quantitative RNA detection in patient material
The limit of detection was 143 RNA copy numbers for
Pfs16. Quantification of Pfs16 copy numbers showed 1.43
times more RNA copies in finger-prick blood compared to
venous blood (Figure 2a). Twenty-five μL of finger-prick
blood would correspond to 35.75 μL of venous blood.
As the sample size was very small and the distribution
of RNA quantities was unknown, parametric significance
tests on the results were inadequate. Therefore sign signifi-
cance tests were chosen. For Pfs16, 11 of the 15 patients
had higher RNA readings for theoretical 100 μL of finger-
prick blood than 100 μL of venous blood. However, the
difference was not significant (p-value 0.095) by Wilcoxon
Signed Rank test. On the other hand, the null hypothesis
that data from 25 μL of finger-prick blood and 100 μL
venous blood were the same could not be rejected
(p-value 0.12) by Wilcoxon Signed Rank test.
The limit of detection for Pfs25 was 1,710 RNA copy
numbers. Quantification of Pfs25 copy numbers showed
3.3 times more RNA copies in theoretical 100 μL
finger-prick blood compared to venous blood (Figure 2b).
Twenty-five μL of finger-prick blood would correspond to
82.6 μL of venous blood.
Figure 1 Qualitative data for 18S-rRNA, the marker for asexual and sexual parasites, Pfs16-mRNA, the marker for all sexual stages, and
Pfs25-mRNA, the marker for mature sexual stages (n = 15). 18S-rRNA: Sensitivity for saliva and urine were 80% and 67%, respectively.
Detection in mucosa samples was the least sensitive method. Pfs16-mRNA: Detection of the target in non-invasively collected material was low.
Urine performed best with a sensitivity of 20%. Pfs25-mRNA: Detection of mRNA amplicons was only achieved in blood samples. Sensitivity of the
methods or size of the RNA fragments in other compartments seems to low for detection with this method.
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the remaining 11 patients had higher RNA readings for
100 μL of finger-prick blood than 100 μL of venous blood.
The null hypothesis that data from 100 μL of finger-prick
blood and 100 μL venous blood were the same could be
rejected (p-value <0.014) by Wilcoxon Signed Rank test.
Comparing 100 μL venous blood and 25 μL finger-prick
blood, there was no evidence for a real difference. The null
hypothesis that data from 25 μL of finger-prick blood and
100 μL venous blood were the same could not be rejected
(p-value 0.964) by Wilcoxon Signed Rank test.
Discussion
In this study, 90 samples from 15 microscopically positive
P. falciparum patients from southwest Ethiopia were tested
for falciparum-specific RNA by QT-NASBA. Microscopy
showed mild to moderate parasitaemia in all, and low
gametocytaemia in 80% of patients. Median gametocyte
density was 7 per 10 μL (range 3-29) corresponding to a
density of 0.3-2.9 gametocytes/μL which is well below the
usual threshold for microscopy of at least 16 gametocytesper μl [24]. Gametocytaemia was only detected by reading
the complete thick smear of 10 μL blood, no gametocytes
were detected by routinely reading 200 fields.
The limit of detection for the gametocyte-specific target
Pfs16 was 143 copy numbers corresponding to very low
submicroscopic densities of gametocytes.
All blood samples were positive for Pfs16-mRNA that is
expressed in all gametocyte stages. Only stage I, micro-
scopically indistinguishable from asexual stages, and stage
V, the mature gametocytes, are found in peripheral blood
in humans. Stages II to IV are sequestered away from cir-
culation [25]. Pfs25-mRNA from mature gametocytes was
detectable in 11 patients. The most probable explanation
for this is that the other four patients had no mature
gametocytes in their peripheral blood yet. Diagnosis of the
disease is most often shortly after onset of symptoms,
mature stages peak at day 7 after onset of symptoms
[25-27], although this is dependent on the treatment.
Secondly, the theoretical limit of detection for Pfs25 was
1,710 RNA copy numbers, about ten times less sensitive
than Pfs16. However, stage-specific expression levels per
Figure 2 Quantitative data for Pfs16-mRNA (a), the marker for all sexual stages, and for Pfs25-mRNA (b), the marker for mature sexual
stages (n = 15). The amount of RNA copy numbers in 25 μL of finger-prick blood was compared to 100 μL of venous blood. The difference was
not significant. The theoretical amount in 100 μL of finger-prick blood was presented to underline the different amounts in capillary and venous
blood. The difference was more prominent for Pfs25-mRNA expressed in mature gametocytes than for Pfs16. 3.3 times more copy numbers could
be assumed in 100 μL capillary blood compared to venous blood.
Kast et al. Malaria Journal 2013, 12:438 Page 7 of 9
http://www.malariajournal.com/content/12/1/438gametocyte are not published for Pfs25 or Pfs16, average
concentration levels of the specific targets are unknown.
As expected, quantification of copy numbers showed
that the density of RNA copy numbers in capillary blood
(finger prick) was higher than in blood from the cubital
vein [28]. The difference was more prominent for mature
gametocytes than for stage I and V together. The chance
to be taken up by mosquitoes is higher in small blood
vessels and more important for stage V.
Comparison of 25 μL finger prick and 100 μL venous
blood showed a higher sensitivity for venous blood but the
difference for Pfs25 was negligible. However, Pfs25 was not
detectable in a finger-prick sample from one patient where
the venous blood sample was positive. Although the density
in capillary blood seems to be higher, the amount of blood
extracted was only 25 μL. For venous blood, 100 μL blood
was extracted. Naturally, the probability to detect anygametocyte increases with the amount of blood extracted
if density is very low. As finger-prick blood is more
convenient and simpler to get in rural areas with its
associated health centres, 25 μL finger-prick blood can
be recommended for mature gametocyte screening in
epidemiological settings.
Probably all or most of the patients with asexual parasit-
aemia carry gametocytes but sensitive rapid diagnostic and
subsequent elimination of all parasites is essential in symp-
tomatic malaria. However, as transmission reduction is of
key importance in eradication efforts, gametocyte-specific
diagnostic is needed to control the success of interventions.
Gametocyte carriage is age-dependent and decreases with
age [25,29]. Density of gametocytes influences the infection
of mosquitoes, very low densities are sufficient but the rela-
tion seems non-linear [24]. Investigation of the infectious
reservoir includes testing for asymptomatic carriers. This
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methods had proved more sensitive. Symptomatic malaria
patients were chosen for the pilot project as higher gameto-
cyte densities were assumed. To investigate further and
reduce the infectious reservoir, finger prick blood spotted
on filter paper seems to be a reliable field-proven method
but should be validated for asymptomatic carriers.
Gametocyte-specific mRNA detection in saliva, urine and
mucosa was low for Pfs16 and negative for Pfs25. Either
mature gametocyte mRNA is not secreted at all or the
sensitivity of the method is too low. Pfs16 could be
found in 20% of urine and 13% of saliva and mucosa
samples. Therefore, the detection rate for non-invasive
methods is unfortunately insufficient. With the methods
used, the fragments amplified were 111 bp for Pfs16-
mRNA and 156 bp for Pfs25-mRNA, respectively. It is
known that mRNA is fragile and decomposes fast outside
of cells. The milieu found during urine filtration and within
urine, as well as on mucosal surfaces is especially delicate
for extracellular mRNA stability. Therefore, part of the poor
detection sensitivity may be due to the decay of the mRNA
into smaller pieces in the respective compartment. Under
the given circumstances, finger-prick blood collection
proved to be the most effective method. Filter paper could
be stored at room temperature if it is processed within
28 days. RNA loss would be on average about 20%. If
storage duration is longer than one month, RNA loss
at room temperature is unacceptably high and the filter
paper should be frozen [9].
Interestingly, mucosa on filter paper performed two to
four times better than fresh frozen mucosal swab. The
swab seems to conserve the RNA less inefficiently than
instant drying and freezing of mucosal swab material on
dry filter paper.
A study from The Gambia on DNA of asexual parasites
showed a good correlation of saliva parasite density as esti-
mated by quantitative real-time PCR (qPCR) with parasite
counts established by microscopy (p = 0.58; P <0.001). Cor-
relation of qPCR results for urine with microscopy counts
was poor (p = 0.20; P =0.117). Mean parasite density in
blood was about 600-fold and 2,500-fold greater than mean
density in saliva and urine samples, respectively. Compared
with microscopy results, nested PCR of saliva had a sen-
sitivity of 73% for all samples and a sensitivity of 82% in
samples with a parasite density of > or = 1,000 parasites/μL;
sensitivity in urine samples was only 32% [11]. PCR-
amplicons had a bigger size than amplicons of the NASBA,
sensitivity was nevertheless similar. The advantage of RNA
is that its detection indicates that there are still living para-
sites circulating in the blood whereas DNA can be positive
several days after acute infection.
The study from Mharakurwa et al. compared blood,
saliva and urine samples from individuals with mostly
aymptomatic parasitaemia. Samples were spotted on filterpaper before extraction. Saliva samples showed a 1.6-fold
higher amplification score than corresponding urine
samples (p = 0.029). DNA amplicons ranged between
229 bp and 643 bp [10].
In this study, 18S-rRNA in saliva was detected in 80% of
the patients. 67% of urine samples yielded RNA. However,
geometric mean parasitaemia (GMP) by microscopy was
higher than in the other studies. GMP in The Gambia was
1,785 parasites/μL (CI 95% 695–4,588 parasites/μL) [11].
Furthermore, samples in the Gambian study were proc-
essed directly within two hours and not spotted on filter
paper before. A recent study about filter paper showed
better results for mRNA detection when the blood was
spotted on filter paper and dried 24 hours before extrac-
tion than direct extraction of fresh blood [9].
Urine and mucosa tissue proved inefficient for the
detection of malaria RNA but saliva analysis as non-
invasive method could be conducted in cross-sectional
and other studies. Primers amplifying smaller fragments
of the target RNA may increase the sensitivity of the test
protocol. Saliva could be tested with various diseases
including malaria. Again, a rapid test would simplify efforts
and allow immediate treatment.
Conclusion
Non-invasively collected material such as urine, saliva or
mucosal swabs seemed unsuitable for the detection of
gametocyte-specific mRNA when protocols established for
blood are used. Detection of 18S-rRNA in saliva was
achieved in 80% of the patients. Combined screening
methods for malaria and other diseases such as tuberculosis
with saliva sampling might speed up diagnosis in future. As
suspected, finger-prick testing revealed the highest absolute
count of RNA copies per μL, especially for Pfs25-mRNA
copies. Comparing the two methods of taking 25 μL finger-
prick blood and drawing 100 μL venous blood for Pfs25-
mRNA, 17.4% less RNA copies in the finger-prick blood
seem acceptable in rural health centres, considering
the ease of withdrawal, the low costs and the tiny blood
volume - especially in small children - by finger-prick
test. The method should be recommended for quantifica-
tion of gametocyte concentrations.
Additional file
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purity of RNA copies for Pfs16 and Pfs25 presented each by a specific peak.
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